Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5609 USD | -1.28% | -10.11% | +9.38% |
May. 20 | Sector Update: Health Care Stocks Ease Monday Afternoon | MT |
May. 20 | Atara Biotherapeutics Files Biologics License Application for Tabelecleucel with FDA; Shares Rise | MT |
Business Summary
Number of employees: 173
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 64 | 100.0 % | 9 | 100.0 % | -86.51% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 64 | 100.0 % | 9 | 100.0 % | -86.51% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Pascal Touchon
CEO | Chief Executive Officer | 61 | 19-06-23 |
Eric Hyllengren
DFI | Director of Finance/CFO | 49 | 17-12-31 |
Anhco Nguyen
CTO | Chief Tech/Sci/R&D Officer | 51 | 21-05-09 |
Dan Maziasz
PRN | Corporate Officer/Principal | - | 17-12-31 |
Jill Henrich
LAW | General Counsel | 61 | - |
K. Murugan
LAW | General Counsel | 49 | 20-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Gallagher
CHM | Chairman | 59 | 12-12-31 |
Eric Dobmeier
BRD | Director/Board Member | 55 | 15-03-25 |
William Heiden
BRD | Director/Board Member | 64 | 15-11-22 |
Matthew Fust
BRD | Director/Board Member | 59 | 14-02-28 |
Director/Board Member | 69 | 20-05-10 | |
Ameet Mallik
BRD | Director/Board Member | 51 | 21-08-08 |
Pascal Touchon
CEO | Chief Executive Officer | 61 | 19-06-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 120,416,138 | 109,222,687 ( 90.70 %) | 0 | 90.70 % |
Company contact information
Atara Biotherapeutics, Inc.
2380 Conejo Spectrum Street Suite 200
91320, Thousand Oaks
+805 623 4211
http://www.atarabio.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.38% | 67.54M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ATRA Stock
- Company Atara Biotherapeutics, Inc.